Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

9,878 total articles

Evergy Director Sells Stock Amid Strong Q1 Performance

Evergy Director Sells Stock Amid Strong Q1 Performance

Director Sandra AJ Lawrence of Evergy, Inc. (NASDAQ:EVRG) executed stock sales totaling $96,215 worth of common shares across two separate transactions during the end of May. These details were documented in a Form 4 filing submitted to the Securities and Exchange Commission on June 1, 2026.The divestiture occurred over two days: on May 28, Ms. Law…

Processa Pharmaceuticals Officer Buys Shares Amid Stock Decline

Processa Pharmaceuticals Officer Buys Shares Amid Stock Decline

Wendy Guy, Chief Administrative Officer at Processa Pharmaceuticals, Inc., recently acquired a block of shares in the company. The purchase occurred on May 29, 2026. This insider transaction is noteworthy given that the stock has experienced a significant decline over the past six months, though current analysis suggests potential undervaluation.

TREACE MEDICAL CONCEPTS CEO Purchases Shares Amid Stock Gains; Q1 Results and Corporate Governance Developments Reported

TREACE MEDICAL CONCEPTS CEO Purchases Shares Amid Stock Gains; Q1 Results and Corporate Governance Developments Reported

John T. Treace, a principal officer and director of TREACE MEDICAL CONCEPTS, INC., recently acquired a significant block of the company's common stock. This transaction occurred while the stock was experiencing substantial gains. Furthermore, recent corporate disclosures included financial results for the first quarter of 2026 that surpassed analys…

Executive Stock Activity and Pipeline Updates for Nuvalent Inc.

Executive Stock Activity and Pipeline Updates for Nuvalent Inc.

Chief Legal Officer Deborah Ann Miller sold a significant block of shares in Nuvalent, Inc. (NASDAQ:NUVL) via an established trading plan. This insider activity is reported alongside substantial positive developments regarding the company's drug pipeline, including the FDA granting Priority Review to neladalkib and presentation of updated data for …